Vice President of Biochemistry and Flow Cell Development. SEATTLE, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single ...

--Curative Biotechnology, Inc. announced today that the Company has reached agreement with Mid-Atlantic BioTherapeutics to broaden its previously announced license of IMT504, a novel patented ...

Vice President of Reagent and Platform Development. SEATTLE, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single ...

Flow Pharma, Inc. and OncoImmunity AS partner for the Development of FlowVax TM Personalized Cancer Vaccines Flow Pharma is now a full-stack biotech company in the neoantigen space Download ...

Improving the flow, handling and interpretation of information is a tremendous accelerant for biotech product development,” said Dr. Michael Fero, Chief Executive Officer, TeselaGen. Terms of ...

SEATTLE, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the ...

SEATTLE, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or "Nautilus"), a company pioneering a single-molecule protein analysis platform for quantifying the proteome ...

SEATTLE, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the ...